ASH 2018 has come and gone, but the numerous abstracts and information presented will be built upon for many years to come. As a first time attendee to the ASH conference, I found it to be a very enriching experience. The abundance of information was overwhelming and seemed to be too much for me to […]
ASH is over but its memories are fresh. My strongest impression of the meeting is that multiple myeloma treatment advances continue to be significant at this huge yearly event. Dr. Durie explained there were an amazing 939 abstracts relating to myeloma at ASH this year. At the IMWG (International Myeloma Working Group) meeting, he said […]
While this year’s ASH had 939 abstracts about multiple myeloma, I agree with Linda Huguelet that this year was a building year, and no real blockbusters. However, and it’s a big however, because there are many future blockbusters expected from the early phase 1 trials as they continue forward, I encourage that you pay attention […]
Well, it’s 5:00 a.m. PT, although I keep telling myself that’s 8:00 a.m. ET, so it doesn’t seem so early. I’m at the San Diego airport waiting for my flight back home from the 2018 American Society of Hematology (ASH) annual meeting and exposition. It has been four, long, intense days of being totally immersed […]
CHARLIE BROWN: Someday we will die, Snoopy. SNOOPY: True, but all the other days, we will not. Snoopy’s philosophy resonates at ASH 2018 because of all the exciting information on immunotherapy. There are new approaches to the use of daratumumab with other agents in quadruple combinations that result in high rate of response in newly […]
I look forward every year to Annual ASH Meeting, whether I’m attending in person or experiencing it from home via Twitter, blogs, and professional writers. At ASH we learn new advances in treating, evaluating, and living with myeloma. Immunology has become a central focus of recent ASH meetings and #ASH18 #IMFASH18 will be more of […]
I am looking forward to shedding my puffy winter jacket and traveling to sunny San Diego to attend the 60th Annual Meeting of the American Society of Hematology (#ASH18) with the International Myeloma Foundation (IMF). This will be the seventh time I have attended ASH, but going to this meeting never gets old. I anxiously […]
As the 60th Annual American Society of Hematology (ASH) meeting approaches, I’m thrilled to join the International Myeloma’s (IMF) team of patient representatives for the 6th time. Each year, I learn more and more and am ever encouraged by the continued passion shown by the researchers. Myeloma may be a rare cancer, but you’d never […]
